Log in
Enquire now
Syndax Pharmaceuticals

Syndax Pharmaceuticals

A pharmaceutical company that develops therapies targeting solid and hematological cancer tumors

OverviewStructured DataIssuesContributors

Contents

syndax.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Cancer immunotherapy
Cancer immunotherapy
Immunotherapy
Immunotherapy
Engineering
Engineering
0
Oncology
Oncology
Biomedical engineering
Biomedical engineering
Biology
Biology
...
Location
New York City
New York City
0
Waltham, Massachusetts
Waltham, Massachusetts
0
New York
New York
United States
United States
B2X
B2B
B2B
0
CEO
‌
Michael A. Metzger
0
Founder
‌
Ronald M. Evans
0
‌
Michael Downes
0
‌
Peter Ordentlich
0
‌
Richard A. Heyman
0
AngelList URL
angel.co/syndax-pha...maceuticals
Pitchbook URL
pitchbook.com/profiles.../14195-62
Legal Name
Syndax Pharmaceuticals, Inc.0
Legal classification
Public company
Public company
0
Number of Employees (Ranges)
51 – 200
Email Address
info@syndax.com0
ir@syndax.com0
clinicaltrials@syndax.com0
Phone Number
+178141914000
+164669076200
Number of Employees
590
Full Address
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA 02451, US
211 East 43rd Street #900 New York, NY 100170
CIK Number
1,395,9370
Place of Incorporation
Delaware
Delaware
0
Investors
Domain Associates
Domain Associates
Pappas Capital
Pappas Capital
0
Tavistock Life Sciences
Tavistock Life Sciences
0
EcoR1 Capital
EcoR1 Capital
0
Boxer Capital
Boxer Capital
Avalon Ventures
Avalon Ventures
RusnanoMedInvest
RusnanoMedInvest
0
Forward Ventures
Forward Ventures
...
DUNS Number
9445460890
IRS Number
320,162,5050
Founded Date
2005
0
Fax Number
781.419.14200
212-867-59020
Total Funding Amount (USD)
65,600,000
Latest Funding Round Date
January 30, 2020
Competitors
OrphAI Therapeutics
OrphAI Therapeutics
0
Stock Symbol
SNDX0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Michael A. Metzger
0
‌
Pierre Legault
0
‌
William Meury
0
‌
Jennifer Jarrett
0
‌
Keith A. Katkin
0
‌
Dennis Podlesak
0
CFO
Keith A. Goldan
Keith A. Goldan
0
Latest Funding Type
Series B
Series B
NAICS Code
325,4120
CAGE Code
63QE10
Patents Assigned (Count)
1
Wellfound ID
syndax-pharmaceuticals
Country
United States
United States

Other attributes

Company Operating Status
Active
Contact Page URL
syndax.com/contact/
Public/Private
Public
SIC Code
2,8340
Ticker Symbol
SNDX0
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Syndax Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.